These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 16892907)
61. Time to recommend pneumococcal vaccination for all children in Europe: experience in France. Fletcher MA; Tetelboum R; Fritzell B Eur J Pediatr; 2002 Dec; 161 Suppl 2():S132-4. PubMed ID: 12494259 [TBL] [Abstract][Full Text] [Related]
62. Prevnar--will it be the next vaccine success story? Fiechtner HB S D J Med; 2003 Sep; 56(9):377-8. PubMed ID: 14524137 [No Abstract] [Full Text] [Related]
63. Pneumococcal polysaccharide vaccine effectiveness: study quality must not be ignored. Trotter C; Scott P; Huss A; Egger M Lancet Infect Dis; 2008 Nov; 8(11):664. PubMed ID: 18992393 [No Abstract] [Full Text] [Related]
64. [Determination of vaccination quotas for pneumococcal conjugate vaccine in children on the basis of routine data of the statutory health insurance]. Theidel U; Braem A; Rückinger S Gesundheitswesen; 2013 May; 75(5):309-16. PubMed ID: 23073984 [TBL] [Abstract][Full Text] [Related]
65. Measuring the impact of PCV7 in the European Union: why it is a priority. Lopalco PL Euro Surveill; 2007 Jun; 12(6):E070614.6. PubMed ID: 17868579 [No Abstract] [Full Text] [Related]
67. Control and prevention of invasive pneumococcal disease in Taiwan: Current achievements and future challenges. Su WJ; Yang CH J Formos Med Assoc; 2019 Jun; 118(6):961-964. PubMed ID: 30773273 [No Abstract] [Full Text] [Related]
68. Prevention of serious bacterial infections in new-onset nephrotic syndrome: a survey of current practices. Shroff A; Frank R; Vergara M; Gauthier B; Trachtman H Clin Pediatr (Phila); 2002; 41(1):47-9. PubMed ID: 11866366 [No Abstract] [Full Text] [Related]
69. Population versus individual protection by pneumococcal conjugate vaccination. Klugman KP; Rodgers GL Lancet; 2019 May; 393(10186):2102-2104. PubMed ID: 31000193 [No Abstract] [Full Text] [Related]
73. [111th Scientific Meeting of the Japanese Society of Internal Medicine: Educational Lecture: 4. Health care for the elderly and vaccination: Current situation of pneumococcal vaccines and pneumococcal diseases]. Oishi K Nihon Naika Gakkai Zasshi; 2014 Sep; 103(9):2247-51. PubMed ID: 27522786 [No Abstract] [Full Text] [Related]
74. Time to increase pneumovac rates. Tracy GE S D J Med; 2002 Sep; 55(9):398. PubMed ID: 12360643 [No Abstract] [Full Text] [Related]
75. [Use of pneumococcal vaccines in children with type 1 diabetes mellitus]. Silva IN; Borges PL; Chagas AJ Rev Assoc Med Bras (1992); 2005; 51(2):72-3. PubMed ID: 15947817 [No Abstract] [Full Text] [Related]
76. Role of Pneumococcal Vaccination in Oncology Patients. Prabhash K; Noronha V; Joshi A J Assoc Physicians India; 2015 Apr; 63(4 Suppl):38-9. PubMed ID: 26562965 [No Abstract] [Full Text] [Related]
77. The indirect effect of pneumococcal conjugate vaccine. Goldblatt D Lancet Glob Health; 2017 Jan; 5(1):e6-e7. PubMed ID: 27955790 [No Abstract] [Full Text] [Related]
78. [Technical guideline on application of pneumococcal vaccine in China (2012)]. Qin Y; Yu HJ; Zhonghua Liu Xing Bing Xue Za Zhi; 2012 Nov; 33(11):1101-10. PubMed ID: 23290891 [No Abstract] [Full Text] [Related]
79. Pneumococcal vaccine in adults with immune-mediated inflammatory diseases. Kapetanovic MC Lancet Rheumatol; 2024 Sep; 6(9):e591-e592. PubMed ID: 39067458 [No Abstract] [Full Text] [Related]
80. [Pneumococcal vaccine in patients infected with the human immunodeficiency virus]. Falcó Ferrer V; Len Abad O; Pahissa Berga A Rev Clin Esp; 2002 Jul; 202(7):395-8. PubMed ID: 12139825 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]